Case and Commentary
Jul 2024
Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD
Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality.
AMA J Ethics. 2024;26(7):E527-533. doi:
10.1001/amajethics.2024.527.